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Background: The potential benefits of earthworm (Pheretima aspergillum) for healing have received considerable
attention recently. Osteoblast and osteoclast activities are very important in bone remodeling, which is crucial to
repair bone injuries. This study investigated the effects of earthworm extract on bone cell activities.
Methods: Osteoblast-like MG-63 cells and RAW 264.7 macrophage cells were used for identifying the cellular effects of
different concentrations of earthworm extract on osteoblasts and osteoclasts, respectively. The optimal concentration
of earthworm extract was determined by mitochondrial colorimetric assay, alkaline phosphatase activity, matrix calcium
deposition, Western blotting and tartrate-resistant acid phosphatase activity.
Results: Earthworm extract had a dose-dependent effect on bone cell activities. The most effective concentration of
earthworm extract was 3 mg/ml, significantly increasing osteoblast proliferation and differentiation, matrix calcium
deposition and the expression levels of alkaline phosphatase, osteopontin and osteocalcin. Conversely, 3 mg/ml
earthworm extract significantly reduced the tartrate-resistant acid phosphatase activity of osteoclasts without altering
cell viability.
Conclusions: Earthworm extract has beneficial effects on bone cell cultures, indicating that earthworm extract is a
potential agent for use in bone regeneration.
Keywords: Earthworm, Osteoblasts, OsteoclastsBackground
Large bone defects caused by trauma, inflammation, tumor
resection, or skeletal abnormalities are a considerable chal-
lenge to reconstructive surgeons. Numerous traditional
Chinese medicines are used to treat bone-related diseases,
including osteoporosis, bone fracture, and arthritis. Many
clinical and animal studies have demonstrated that they
have therapeutic effects on bone regeneration [1,2]. The
earthworm is widely used in traditional oriental medicine
to treat cardiovascular diseases and antipyretic [3,4]. The
earthworm’s body cavity contains coelomic fluid, which has
several biological activities such as antibacterial, hemolytic,* Correspondence: chyao@mail.cmu.edu.tw
†Equal contributors
1School of Chinese Medicine, China Medical University, 91 Hsueh-Shih Road,
Taichung 40402, Taiwan
4Department of Biomedical Imaging and Radiological Science, China Medical
University, Taichung 40402, Taiwan
Full list of author information is available at the end of the article
© 2014 Fu et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.agglutinative, and mitogenic activities [5-9]. Increasing
amounts of evidence indicate that earthworm extract has
various beneficial pharmacological activities, including fi-
brinolytic and anticoagulative activities, hepatoprotective
activity, and antioxidative activity [10-14]. Moreover, earth-
worm extract can enhance wound healing and periph-
eral nerve regeneration [15-18]. The anti-inflammatory
and antioxidant activities may be attributed to the high
polyphenolic content in earthworm tissue [19]. The gly-
colipoprotein extract (G-90) obtained from the tissue
homogenate of earthworms exhibits antioxidative, fi-
brinolytic, and anticoagulative activities [11,12]. G-90
contains several growth factors, including insulin-like
growth factor, immunoglobulin-like growth factor, and
epidermal growth factor [13]. It also participates in tis-
sue regeneration and wound healing.
This study evaluated the biological effects of various
concentrations of earthworm extract on osteoblast andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of our knowledge, this study is the first to evaluate the
effects of earthworm extract on the bone cells activities.
Bone cell activities were assessed using the tetrazolium
bromide colorimetric assay, alkaline phosphatase (ALP)
activity assay, matrix calcium deposition, Western blot-
ting assay and the tartrate-resistant acid phosphatase
(TRAP) activity assay.Methods
Preparation of earthworm extract
Dried earthworms were obtained from the Chung Song
Zong Pharmaceutical Co. (Kaohsiung, Taiwan). Their iden-
tity was confirmed by experts in pharmacognosy. Earth-
worm extract was prepared using a method described
previously [18]. Briefly, 600 g dried earthworm was added
to 7.2 l deionized water and boiled at 100°C for 1 h. The
residue was volatilized at room temperature. Another ex-
tract was obtained from the pretreated earthworm by boil-
ing deionized water for two times [water-to-earthworm
ratios (ml/g) at 10:1 and 8:1] for 1 h. The aqueous extracts
were filtered to remove insoluble debris and concentrated
at 65°C via vacuum evaporation to 2.3 g/ml (equivalent to
the dry weight of earthworms) and stored at 4°C until
in vitro assays.Osteoblast culture
The cellular effects of earthworm extract on osteo-
blasts were assessed using the human osteoblast-like
cell line MG-63 (BCRC no. 60279, Food Industry Re-
search and Development Institute, Hsinchu, Taiwan).
Cells were cultured in a growth medium consisting of
Dulbecco’s modified Eagle’s medium (DMEM; Gibco,
Grand Island, NY, USA), 10% fetal bovine serum (FBS;
Gibco) and 1% penicillin/streptomycin (Gibco) at 37°C
under 5% CO2 in humidified air. The medium was
changed every 2 days. Adherent cells were allowed to
reach roughly 80% confluence. The cells were then
passaged in the culture. Passage 2 culture was used for
all in vitro assays. Cultured MG-63 cells were seeded
in growth medium in 96-well plates at a density of 1 ×
104 cells/well. After 1 day of incubation, the culture
medium was replaced with mixed solutions of a new
culture medium and various concentrations of earth-
worm extract at a ratio of 9:1 (v/v) [20]. In the control
group, the culture medium for cell cultures was mixed
with phosphate-buffered saline (PBS) at a ratio of 9:1
(v/v). After culturing for 2 days, osteoblast proliferation
and differentiation were assessed by 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrazoliumbromide (MTT; USB,
Amersham Life Science, Cleveland, OH, USA) assay and
ALP activity assay, respectively.RAW 264.7 culture
The effects of earthworm extract on osteoclast proliferation
and differentiation were evaluated using murine monocyte/
macrophage RAW 264.7 cells (BCRC No. 60001, Food
Industry Research and Development Institute). 2 × 103
cells/well RAW 264.7 cells were seeded in individual wells
of a 48-well tissue culture plate in a growth medium. After
1 day of incubation, osteoclast differentiation from RAW
264.7 cells was induced with 50 ng/ml RANKL (Enzo Life
Sciences, Lausen, Switzerland) in α-minimal essential
medium (α-MEM; Gibco) with 10% FBS for 6 days because
the formation of mature osteoclasts requires 5–6 days
[21-23]. The culture medium was refreshed every 2 days.
After 6 days culturing, the culture medium was replaced
with mixed solutions of new culture medium and various
concentrations of earthworm extract at a ratio of 9:1 (v/v).
In the control group, the culture medium was mixed
with PBS at a ratio of 9:1(v/v) for cell cultures. After
2 days of culture, osteoclast proliferation and differenti-
ation were determined by MTT assay and TRAP activity
assay, respectively.
MTT assay for cell proliferation
After incubation for 2 days, the supernatant was removed.
Then, 10 μl MTT solution (5 mg/ml) and 100 μl culture
medium were added to each well. The plate was incubated
at 37°C for 4 h to facilitate the formation of insoluble for-
mazan crystals. The solution was then removed and
100 μl/well acidic isopropyl alcohol (0.04 M HCl in isopro-
pyl alcohol) was added to dissolve the dark-blue formazan
crystals. After shaking for a few minutes, the concentration
of intracellular formazan crystals was determined at a test
wavelength of 570 nm against a reference wavelength of
650 nm by an enzyme-linked immunosorbent assay
(ELISA) reader (uQuant; Bio-Tek Instruments, Inc.,
Sunnyvale, CA, USA). The number of viable cells in
each well was calculated by transforming the optical
density values of the MTT assay into numbers of cells/
well, based on a standard curve. All experiments were
performed in triplicate.Liu’s stain for morphological observation and osteoblast
proliferation
Liu’s stain was applied to observe osteoblast morphology
and proliferation [24]. After culturing for 2 days, the cell
layers were rinsed three times with PBS, fixed in 2% glu-
taraldehyde (Acros, Geel, Belgium) for 30 min, and stained
with Liu’s stain solution (30 s in solution A, followed by
90 s in solution B) (Chin Pao Co., Ltd., Taipei, Taiwan).
After washing three times with deionized water to remove
the remaining stain, the cell layers were observed using an
inverted optical microscope (Axiovert 25; Carl Zeiss, Inc.,
Goettingen, Germany).
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differentiation
After 2 days of culturing, the medium was replaced with
20 μl/well 0.1% Triton X-100 (Sigma) and incubated at
room temperature for 5 min for cell lysis. 100 μl/well of
the commercially available ALP assay kit (Procedure No.
DG1245-K; Sigma) was then added within 1 min. Ab-
sorbance at 405 nm caused by p-nitrophenol production
was assessed for 30 min at room temperature. The
change in rate of absorbance was directly proportional
to ALP activity. Each experimental condition was re-
peated three times.
Analysis of matrix calcium deposition
Von Kossa stain was utilized to examine the formation of
the mineralized matrix [25]. Briefly, 5 × 104 cells/well cul-
tured MG-63 cells were added to the osteogenic medium
(growth medium supplemented with 50 μg/ml L-ascorbic
acid (Sigma), 10 mM β-glycerol phosphate (Sigma) and 10
nM dexamethasone (Sigma) in a 35-mm culture dish. The
medium was mixed with various concentrations of earth-
worm extract at a ratio of 9:1 (v/v). In the control group,
the medium was mixed with PBS at a ratio of 9:1 (v/v) for
cell cultures. The medium was changed every 3 days. After
culturing for 14 days, cultures were washed with PBS
twice and fixed in 2% glutaraldehyde for 20 min. After in-
cubation for 30 min with 5% silver nitrate (Union Chem-
ical Works, Ltd., Hsinchu, Taiwan) in darkness at room
temperature, cells were rinsed twice in deionized water.
After drying in air, cells were exposed to ultraviolet light
for 1 h until color development was complete. The cells
were then immersed in 5% sodium thiosulfate (Union
Chemical Works, Ltd.) for 2 min. Finally, calcification was
visualized by counterstaining cells with 0.1% nuclear fast
red (Sigma) dissolved in 5% aluminum sulfate (JT Baker,
Phillipsburg, NJ, USA) for 5 min. Following rinsing in de-
ionized water, matrix calcium deposition was observed
with an optical microscope.
Western blot analysis
Western blot analysis was performed to study the ex-
pression of ALP, osteopontin and osteocalcin of osteo-
blasts while interacting with earthworm extract. Briefly,
4 × 105 cells/well cultured MG-63 cells were seeded to
osteogenic medium in a 6-well culture plate. After cul-
turing for 1 day, the culture medium was replaced with
mixed solutions of a new culture medium and various
concentrations of earthworm extract at a ratio of 9:1 (v/v).
In the control group, the culture medium was mixed with
PBS at a ratio of 9:1 (v/v) for cell cultures. The medium
was refreshed every 3 days. After culturing for 7 days, ad-
herent cells were washed twice with PBS and lysed in ice-
cold lysate buffer. Cellular lysates were centrifuged at
12000 g for 30 min at 4°C. The supernatant was recovered,and the protein concentration was determined by the
Bradford protein assay (Bio-Rad, Hercules, CA). 30 μg/μl
protein was separated by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to the poly(vinylidene difluoride) membranes.
Nonspecific binding sites were blocked with 3% skim
milk in PBS for 30 min. Membranes were then incubated
with primary antibodies at 1:1000 dilutions in mouse anti-
ALP, osteopontin or osteocalcin for 2 days. The mem-
branes were washed to remove unbound antibodies and
then incubated with the secondary antibody (horseradish
peroxidase-conjugated anti-rabbit IgG) diluted at 1:1000
for 90 min. Finally, blots were visualized by enhanced
chemiluminescence (ECL) kit (Pierce, Rockford, IL, USA)
using X-ray film (Konica Minolta, Japan).
Analysis of TRAP for osteoclast differentiation
After 2 days of culturing, TRAP activity was assessed by
measuring the amount of acid phosphatase (ACP) released
from cells into the medium using a commercially available
kit (Procedure No. 435, Sigma). Briefly, 30 μl culture
media was mixed with 100 μl acid phosphatase reagent.
Absorbance at 405 nm caused by p-nitrophenol produc-
tion was observed for 30 min at room temperature. The
change in rate of absorbance was directly proportional to
TRAP activity. Each experimental condition was repeated
three times.
Statistical analysis
Numerical data are presented as mean ± SD. Statistical
analysis was performed using one-way analysis of variance
(ANOVA), followed by post hoc Fisher’s LSD multiple
comparison test. Statistical significance was p < 0.05.
Results
Earthworm extract enhances osteoblast proliferation
Figure 1 shows the effects of different concentrations of
earthworm extract on osteoblast proliferation measured
by MTT assay after 2 day of culture. Osteoblast prolifera-
tion was dose-dependent for high concentrations of earth-
worm extract. Treatment with earthworm extract at
concentrations from 500 μg/ml to 6 mg/ml significantly
enhanced osteoblast proliferation (p < 0.05). Particularly,
3 mg/ml earthworm extract increased cell proliferation
most (p < 0.01), in which the number of osteoblasts was
54% higher than that in the control group. However, the
number of osteoblasts decreased significantly when the
earthworm extract concentration was > 6 mg/ml (p < 0.05).
Notably, 12 mg/ml earthworm extract significantly inhib-
ited osteoblast proliferation (p < 0.001), in which the num-
ber of osteoblasts was 43% lower than that in the control
group. It indicated that 12 mg/ml earthworm extract was
likely toxic to osteoblasts. These analytical results were fur-






























Figure 1 Earthworm extract enhances the proliferation of osteoblasts. MG-63 cells were cultured with PBS as a control or different concentrations
of earthworm extract. Osteoblast viability was measured by MTT assay after 2 day of culture. (*p < 0.05, **p < 0.01 and ***p < 0.001 vs. control; #p < 0.05
and ###p < 0.001 vs. 3 mg/ml).
Fu et al. BMC Complementary and Alternative Medicine 2014, 14:440 Page 4 of 9
http://www.biomedcentral.com/1472-6882/14/440Figure 2 shows the morphology of osteoblasts cultured
with various concentrations of earthworm extract for
2 days. The osteoblasts displayed spindle-shaped. The
morphology of osteoblasts did not obviously differ between
the control group and experimental groups. However, the
number of osteoblasts increased as the concentration of
earthworm extract increased from 0.5 μg/ml to 3 mg/ml,
and then decreased as the concentration was raised further.
Particularly, treatment with 12 mg/ml earthworm extract
reduced the osteoblast population as compared with that
of the control group. Similar findings were obtained by
MTTanalysis.Earthworm extract stimulates osteoblast differentiation
ALP, a membrane-bound enzyme, is a differentiation
marker of early osteoblasts. Differentiated osteoblasts
exhibit elevated ALP activity, which correlates with high
levels of enzyme expression [26]. Treatment of MG-63
cells with earthworm extract for 2 days stimulated the
ALP activity of osteoblasts in a dose-dependent manner
(Figure 3). Compared with the control group, the ALP
activity was significantly increased when the concentra-
tion of earthworm extract was between 500 ng/ml and
3 mg/ml (p < 0.05). Notably, at higher concentrations
(1 and 3 mg/ml), ALP activity increased significantly
by about 1.4-fold (p < 0.001). However, at 6 mg/ml,
ALP activity of osteoblasts did not differ significantly from
that of the control group (p > 0.05). Moreover, at 12 mg/ml,
ALP activity was significantly lower than that of the control
group (p < 0.05).Earthworm extract induces matrix calcium deposition
Von Kossa staining is specific for the calcified extracel-
lular matrix [27]. Dark staining of nodules demonstrates
deposition of the mineralized matrix of bone formation.
Figure 4 shows the effect of various concentrations of
earthworm extract on matrix calcium deposition after
14 days of incubation. Osteoblasts cultured in medium
containing 500 μg/ml to 3 mg/ml earthworm extract had
high matrix mineralization. However, mineralization of os-
teoblasts treated with 12 mg/ml earthworm extract was
not observed after culturing for 14 days.
Earthworm extract stimulates the expression of
osteogenic-related proteins
Western blot analysis was applied to observe the expres-
sion of osteogenic-related proteins after treatment with
different concentrations of earthworm extract for 7 days.
All ALP, osteopontin and osteocalcin expression levels
on earthworm extract-treated osteoblasts were higher
than those of the control group (Figure 5). Cells cultured
with medium containing 500 μg/ml to 6 mg/ml, 5 μg/ml
to 6 mg/ml and 500 μg/ml to 6 mg/ml earthworm ex-
tract had higher upregulation of ALP, osteopontin and
osteocalcin expression, respectively. Particularly, osteo-
blasts treated with 3 mg/ml earthworm extract had the
highest ALP expression.
Earthworm extract has no effect on the proliferation
of osteoclasts
The RAW 264.7 cells were used to investigate the osteo-
clastogenic effect of earthworm extract. Figure 6 displays







Figure 2 The morphology and proliferation of osteoblasts treated with various concentrations of earthworm extract. MG-63 cells were
treated with PBS as a control or different concentrations of earthworm extract. After 2 day of culture, the cell layers were stained with Liu’s stain
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ALP Activity Assay (Osteoblasts)
Figure 3 Earthworm induces the differentiation of osteoblasts. MG-63 cells were cultured with PBS as a control or different concentrations
of earthworm extract. After culturing for 2 days, osteoblast differentiation was assessed by ALP activity assay. Results are expressed as percentage
of control (*p < 0.05, **p < 0.01 and ***p < 0.001 vs. control; ###p < 0.001 vs. 3 mg/ml).
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Figure 4 Earthworm extract stimulates matrix calcium deposition by osteoblasts. MG-63 cells were cultured in osteogenic medium mixed
with PBS as a control or different concentrations of earthworm extract. After 14 day of culture, matrix calcium deposition was determined using
von Kossa staining. Arrows demonstrate deposition of mineralized matrix.
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osteoclasts assessed by MTT assay after treatment with
various concentrations of earthworm extract for 2 days.
No significant difference in number of osteoclasts
existed between the control group and experimental
groups (p > 0.05), indicating that all test dosages (500 ng/ml
to 6 mg/ml) of earthworm extract had no cytotoxic effects
on osteoclasts.
Earthworm extract inhibits the differentiation
of osteoclasts
The effect of earthworm extract on osteoclast differenti-
ation was evaluated by TRAP, a marker of osteoclast differ-
entiation [28]. Figure 7 shows TRAP activity assay results
for osteoclasts cultured with various concentrations ofALP
Osteopontin
Control 500 ng/ml 5 µg/ml 50 µg/ml
Osteocalcin
Figure 5 Earthworm extract stimulates the expression of osteogenic-
expression of ALP, osteopontin and osteocalcin of osteoblasts after treatme
extract for 7 days.earthworm extract for 2 days. A dose-dependent response
for TRAP activity existed. Earthworm extract at concen-
trations < 3 mg/ml markedly decreased the TRAP activ-
ity of osteoclasts as compared with that of the control
group (p < 0.05). Inhibition of TRAP activity was stronger
when the earthworm extract concentration was < 500 μg/ml
(p < 0.05). However, 6 mg/ml earthworm extract had no sig-
nificant effect on TRAP activity (p > 0.05).
Discussion
Bone remodeling, an important process in the renewal
and repair of damaged bone, is initiated by osteoclastic
bone resorption and subsequent osteoblastic bone forma-
tion. Previous studies have shown that several Chinese
medicines significantly affect bone cell activities and57 kDa
66 kDa
500 µg/ml 1 mg/ml 6 mg/ml3 mg/ml
12 kDa
related proteins. Western blot analysis was applied to observe the




















lm/gm6lm/gn005 3 mg/ml5 µg/ml 
Concentration
1 mg/ml500 µg/ml 50 µg/ml Control
Figure 6 Earthworm extract does not affect the proliferation of osteoclasts. RAW 264.7 cells were seeded in 48-well plates and allowed to
adhere for 1 day. Osteoclast differentiation from RAW 264.7 cells was induced with 50 ng/ml RANKL in α-MEM for 6 days. Osteoclasts were then
cultured with PBS as a control or different concentrations of earthworm extract for 2 days. Osteoclast viability was measured by MTT assay.
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been used as a crude drug for thousands of years in China
and the wider Asian region [10]. Earthworm extract can
promote the differentiation of neurite-bearing cells and
the proliferation and migration ability of RSC96 Schwann


























Figure 7 Earthworm extract inhibits the differentiation of osteoclasts
for 1 day. Osteoclast differentiation from RAW 264.7 cells was induced with
with PBS as a control or different concentrations of earthworm extract for 2
Results are expressed as percentage of control (*p < 0.05 and **p < 0.01 vs.extract markedly enhanced the nerve growth factor-
mediated neurite outgrowth from PC 12 cells. Chang et al.
[35] reported that treatment with 125 μg/ml earthworm ex-
tract for 24 h induced RSC96 cells proliferation. However,
toxicity occurred at high concentrations (250–1000 μg/ml).
Moreover, Grdiša et al. [12] found that glycolipoprotein Assay (Osteoclasts)
6 mg/ml3 mg/ml
entration




. RAW 264.7 cells were seeded in 48-well plates and allowed to adhere
50 ng/ml RANKL in α-MEM for 6 days. Osteoclasts were then cultured
days. Osteoclast differentiation was determined by TRAP activity assay.
control).
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against H2O2 toxicity and stimulated the growth of human
fibroblasts and epithelial cells. Additionally, Grdiša et al.
[15] found that earthworm extract stimulated the synthesis
of epidermal growth factor and fibroblast growth factor
during wound healing on mice skin. Additionally, lumbro-
kinase is an important protease derived from earthworms
[36]. Recent investigations have found that lumbrokinase
has protective effects on hippocampus apoptosis, thera-
peutic potential in diabetic nephropathy and anti-ischemic
action in brain [37-39].
This study evaluated for the first time the effects of
earthworm extract on bone cell activities. Earthworm ex-
tract significantly promoted the proliferation, differenti-
ation and matrix calcium deposition of osteoblasts. The
most effective concentration of earthworm extract in en-
hancing osteoblasts proliferation and differentiation was
3 mg/ml. However, they were inhibited by high concen-
tration (12 mg/ml), indicating that excessive earthworm
extract can have an adverse effect on osteoblasts.
Osteoblasts produce ALP, osteopontin and osteocalcin,
which are bone-specific markers [40]. Among these pro-
teins, ALP and osteopontin are early markers of osteo-
blastic differentiation. Osteocalcin directly participates
in the mineralization process and is a marker for mature
osteoblasts that is expressed in the late stages of osteo-
genic differentiation. Moreover, osteopontin and osteo-
calcin are extracellular matrix proteins and crucial for
bone tissue formation. The Western blot analysis results
show that 3 mg/ml earthworm extract-treated osteo-
blasts expressed the highest level of ALP with higher
levels of osteopontin and osteocalcin. It indicates that
earthworm extract stimulated early differentiation of os-
teoblasts and is favorable for osteoblast mineralization.
Calcium deposition results by von Kossa staining were
in agreement with these analytical results. The most ef-
fective concentration of earthworm extract for matrix cal-
cium deposition was between 500 μg/ml and 3 mg/ml.
These results reveal that the capacity to form matrix
mineralization was positively correlated with osteoblast
proliferation and differentiation.
The experiments also show that 3 mg/ml earthworm ex-
tract did not significantly affect osteoclast proliferation.
However, 3 mg/ml earthworm extract reduced the amount
of TRAP, indicating that it inhibited osteoclast activity.
These analytical results demonstrate that 3 mg/ml earth-
worm extract can be used for bone repair because it can
promote osteoblast proliferation and differentiation as well
as inhibit osteoclast activity.
Conclusions
Our findings show that an appropriate dose of earthworm
extract has potential effects on bone cell cultures. There-
fore, earthworm extract might be a promising agent forbone tissue regeneration. Nevertheless, this research is
only preliminary in evaluating the effects of earthworm ex-
tract on bone cell activities. Further studies are needed to
identify the specific interactions between different earth-
worm components and bone cells and to determine the
exact bioactive compounds in earthworm extract that are
responsible for bone cell activities.
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